Welcome to LookChem.com Sign In|Join Free
  • or
2H-Benzimidazole-2-thione,4-chloro-1,3-dihydro-(9CI) is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

75335-72-7

Post Buying Request

75335-72-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

75335-72-7 Usage

Chemical compound

2H-Benzimidazole-2-thione,4-chloro-1,3-dihydro-(9CI)

Classification

Benzimidazole derivative with chlorine atom at the 4th position

Potential pharmaceutical uses

Exhibits anticancer, antimicrobial, antiviral, and antiparasitic properties

Biological activity

Can alter biological activity and pharmacokinetic characteristics of benzimidazole compounds

Importance for drug development and research

Valuable chemical for potential drug development

Safety precautions

Handle and store with proper safety precautions due to potential biological activity and reactivity.

Check Digit Verification of cas no

The CAS Registry Mumber 75335-72-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,5,3,3 and 5 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 75335-72:
(7*7)+(6*5)+(5*3)+(4*3)+(3*5)+(2*7)+(1*2)=137
137 % 10 = 7
So 75335-72-7 is a valid CAS Registry Number.

75335-72-7Relevant academic research and scientific papers

Synthesis and NMR spectroscopic assignment of chlorinated benzimidazole-2-thione derivatives

Proj, Matic,Sosi?, Izidor,Gobec, Stanislav

supporting information, (2019/08/30)

The benzimidazole-2-thione scaffold is present in many drugs encompassing various therapeutic areas. Due to the broad spectrum of bioactivities it also represents an important starting point in drug discovery campaigns, especially those based on fragment-

Potent, Selective, and Cell Active Protein Arginine Methyltransferase 5 (PRMT5) Inhibitor Developed by Structure-Based Virtual Screening and Hit Optimization

Mao, Ruifeng,Shao, Jingwei,Zhu, Kongkai,Zhang, Yuanyuan,Ding, Hong,Zhang, Chenhua,Shi, Zhe,Jiang, Hualiang,Sun, Dequn,Duan, Wenhu,Luo, Cheng

, p. 6289 - 6304 (2017/08/02)

PRMT5 plays important roles in diverse cellular processes and is upregulated in several human malignancies. Besides, PRMT5 has been validated as an anticancer target in mantle cell lymphoma. In this study, we found a potent and selective PRMT5 inhibitor by performing structure-based virtual screening and hit optimization. The identified compound 17 (IC50 = 0.33 μM) exhibited a broad selectivity against a panel of other methyltransferases. The direct binding of 17 to PRMT5 was validated by surface plasmon resonance experiments, with a Kd of 0.987 μM. Kinetic experiments indicated that 17 was a SAM competitive inhibitor other than the substrate. In addition, 17 showed selective antiproliferative effects against MV4-11 cells, and further studies indicated that the mechanism of cellular antitumor activity was due to the inhibition of PRMT5 mediated SmD3 methylation. 17 may represent a promising lead compound to understand more about PRMT5 and potentially assist the development of treatments for leukemia indications.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 75335-72-7